Amyloid-beta 11 (N-Term) Antikörper
Reaktivität: Human
IHC, ELISA, WB
Wirt: Kaninchen
Polyclonal
unconjugated
-
- Target
- Amyloid-beta 11
- Bindungsspezifität
- N-Term
- Reaktivität
- Human
- Wirt
- Kaninchen
- Klonalität
- Polyklonal
- Applikation
- Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
- Aufreinigung
- Affinity Purified
- Immunogen
- A synthetic peptide corresponding to the N-terminus 11-pyro E start point.
- Isotyp
- IgG
-
- Applikationshinweise
- ELISA , Western (immuno) blotting (in testing), Immunostaining (in testing)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
- Target
- Amyloid-beta 11
- Hintergrund
- Pyroglutamic acid truncated amyloid beta 11-40/42 may have a greater propensity to aggregate under physiological conditions. In addition, this pyrE modification has been implicated as the molecular species responsible for seeding larger oligomers of amyloid-beta. Pyroglutamic acid truncated amyloid beta 11-40/42 s exact involvement in the pathophysiology of Alzheimer s disease has not been established
- Gen-ID
- 351
- UniProt
- P05067
-
Sie sind hier:
